The Company has incurred substantial operating losses since its inception and
expects to continue to incur significant operating losses for the foreseeable
future and may never become profitable. As reflected in the condensed financial
statements, the Company had an accumulated deficit of approximately $68.3
million at September 30, 2021, a net loss of approximately $11.1 million, and
approximately $5.6 million of net cash used in operating activities for the six
months ended September 30, 2021. The Company expects to continue to incur
ongoing administrative and other expenses, including public company expenses.



In November 2021, the Company entered into a non-binding term sheet with a
financial institution in connection with a $10 million Standby Letter of Credit
("SLOC"). The SLOC accrues interest at a rate of 8% per annum and matures two
years from the issuance date of the SLOC. Interest is payable quarterly.



Although it is difficult to predict the Company's liquidity requirements as of
September 30, 2021, based upon the Company's current operating plan, cash on
hand, and SLOC funding, management believes that the Company will have
sufficient cash to meet its projected operating requirements for at least the
next 12 months following the issuance of these condensed financial statements.



Management is constantly monitoring the impact of the COVID-19 pandemic on
operations and financials of the Company. To date the main impact has been the
delayed evaluation of potential manufacturing partnerships. These delays have
been caused by Covid lockdowns i) restricting site tour opportunities by
potential partners and ii) driving strong demand for potential partners existing
product lines, limiting their capacity to assess new partnership opportunities.
The Company has concluded that while it is reasonably possible that the virus
could still have a negative effect on the Company's financial position, the
specific impact is not readily determinable as of the date of these condensed
financial statements. The condensed financial statements do not include any
adjustments that might result from the outcome of this uncertainty.



                                       6





                          CROWN ELECTROKINETICS, CORP.
                    Notes to Condensed Financial Statements
                 Three and six months ended September 30, 2021
                                  (Unaudited)


Note 3 - Significant Accounting Policies





For a detailed discussion about the Company's significant accounting policies,
see the Company's financial statements included in its Annual Report for the
fiscal year ended March 31, 2021.



Basis of Presentation



The Company's condensed financial statements have been prepared in conformity
with accounting principles generally accepted in the United States of America
("GAAP") and include all adjustments necessary for the fair presentation of the
Company's financial position for the periods presented. The results of
operations for the three and six months ended September 30, 2021 are not
necessarily indicative of the results for the full year or the results for any
future periods. These condensed financial statements should be read in
conjunction with the audited financial statements and related notes for the
fiscal year ended March 31, 2021 included in the Company's Form 10-K filed with
the Securities and Exchange Commission (the "SEC") on June 21, 2021.



Use of Estimates



The preparation of financial statements in conformity with GAAP requires
management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at
the date of the financial statements and the reported amounts of expenses during
the reporting period. These estimates and assumptions are based on current
facts, historical experience and various other factors believed to be reasonable
under the circumstances, the results of which form the basis for making
judgments about the carrying values of assets and liabilities and the recording
of expenses that are not readily apparent from other sources. Actual results may
differ materially and adversely from these estimates. To the extent there are
material differences between the estimates and actual results, the Company's
future results of operations will be affected.



Net Loss per Share



ASC 260, Earnings Per Share, requires dual presentation of basic and diluted
earnings per share ("EPS") with a reconciliation of the numerator and
denominator of the basic EPS computation to the numerator and denominator of the
diluted EPS computation. Basic EPS excludes dilution. Diluted EPS reflects the
potential dilution that could occur if securities or other contracts to issue
common stock were exercised or converted into common stock or resulted in the
issuance of common stock that then shared in the earnings of the entity.



Basic net loss per share of common stock excludes dilution and is computed by
dividing net loss by the weighted average number of shares of common stock
outstanding during the period. Diluted net loss per share of common stock
reflects the potential dilution that could occur if securities or other
contracts to issue common stock were exercised or converted into common stock or
resulted in the issuance of common stock that then shared in the earnings of the
entity unless inclusion of such shares would be anti-dilutive. Since the Company
has only incurred losses, basic and diluted net loss per share is the same.
Securities that could potentially dilute loss per share in the future that were
not included in the computation of diluted loss per share at September 30, 2021
and 2020 are as follows (unaudited):



                                                                       September 30,
                                                                   2021             2020
Series A preferred stock                                            188,311                -
Series B preferred stock                                          2,019,038                -
Series C preferred stock                                            560,757                -

Warrants to purchase common stock (excluding penny warrants) 4,300,177

1,921,452


Options to purchase common stock                                 10,920,432

4,683,389


Unvested restricted stock awards                                          -

1,000,004


Unvested restricted stock units                                   2,039,683                -
Convertible notes                                                         -        2,805,941
                                                                 20,028,398       10,410,786






                                       7





                          CROWN ELECTROKINETICS, CORP.
                    Notes to Condensed Financial Statements
                 Three and six months ended September 30, 2021
                                  (Unaudited)


JOBS Act Transition Period


The Company is considered to be an "emerging growth company" as defined in the
Jumpstart Our Business Startups Act of 2012, as amended (JOBS Act). The JOBS Act
provides that an emerging growth company can take advantage of an extended
transition period for complying with new or revised accounting standards. Thus,
an emerging growth company can delay the adoption of certain accounting
standards until those standards would otherwise apply to private companies. The
Company has elected to use the extended transition period for complying with any
new or revised financial accounting standards pursuant to Section 13(a) of the
Securities and Exchange Act of 1934.



Recent Accounting Pronouncements





In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260),
Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock
Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity's Own
Equity (Subtopic 815-40). This ASU reduces diversity in an issuer's accounting
for modifications or exchanges of freestanding equity-classified written call
options (for example, warrants) that remain equity classified after modification
or exchange. This ASU provides guidance for a modification or an exchange of a
freestanding equity-classified written call option that is not within the scope
of another Topic. It specifically addresses: (1) how an entity should treat a
modification of the terms or conditions or an exchange of a freestanding
equity-classified written call option that remains equity classified after
modification or exchange; (2) how an entity should measure the effect of a
modification or an exchange of a freestanding equity-classified written call
option that remains equity classified after modification or exchange; and (3)
how an entity should recognize the effect of a modification or an exchange of a
freestanding equity-classified written call option that remains equity
classified after modification or exchange. This ASU will be effective for all
entities for fiscal years beginning after December 15, 2021. An entity should
apply the amendments prospectively to modifications or exchanges occurring on or
after the effective date of the amendments. Early adoption is permitted,
including adoption in an interim period. The adoption of ASU 2021-04 is not
expected to have a material impact on the Company's financial statements or
disclosures.



Note 4 - Property & Equipment, Net

Property and equipment, net, consists of the following (in thousands):





                                                  September 30,       March 31,
                                                      2021              2021
                                                   (Unaudited)
Equipment                                        $           563     $       295
Computers                                                     27              11
Leasehold improvements                                        20              14
Construction in progress                                      25               -
Total                                                        635             320

Less accumulated depreciation and amortization              (151 )          (111 )
Property and equipment, net                      $           484     $     

 209




Depreciation expense for the three months ended September 30, 2021 and 2020 was
approximately $21,000 and $5,000 respectively. Depreciation expense for the six
months ended September 30, 2021 and 2020 was approximately $40,000 and $15,000
respectively.



                                       8





                          CROWN ELECTROKINETICS, CORP.
                    Notes to Condensed Financial Statements
                 Three and six months ended September 30, 2021
                                  (Unaudited)


Note 5 - Intangible Assets, Net


During the six months ended September 30, 2021, the Company entered into a
Patent Assignment Agreement with International Business Machines Corporation
("IBM") to acquire an ownership interest in assigned patents. As consideration
for the patents, the Company paid $231,000 (including legal fees of
approximately $6,000) during the six months ended September 30, 2021.



Intangible assets, net, consists of the following (in thousands):





                            September 30,       March 31,
                                2021              2020
                             (Unaudited)
Patents                    $         1,706     $     1,475
Research license                       375             375
Total                                2,081           1,850
Accumulated amortization              (298 )          (200 )
Research license, net      $         1,783     $     1,650




The following table represents the total estimated amortization of intangible
assets for the five succeeding years and thereafter as of September 30, 2021 (in
thousands):



                        Estimated
                      Amortization
                         Expense         Rounding Check
                       (Unaudited)
2022                  $         105                  105
2023                            211                  211
2024                            211                  211
2025                            211                  211
2026 and thereafter           1,045                1,045
Total                 $       1,783                1,783




For the three months ended September 30, 2021 and 2020, amortization expense was
approximately $51,000 and $10,000, respectively. For the six months ended
September 30, 2021 and 2020, amortization expense was approximately $98,000

and
$20,000, respectively.



Note 6 - Accrued Expenses


As of September 30, 2021 and March 31, 2021, the Company's accrued expenses consisted of the following (in thousands):

September 30,
                                                  2021            March 31, 2021
                                               (Unaudited)

Directors and officers insurance financing   $             -     $            160
General liability insurance                              388                    -
Professional fees                                          -                   49
Rent                                                      91                    -
Other                                                      1                    2
Total                                        $           480     $            211




                                       9





                          CROWN ELECTROKINETICS, CORP.
                    Notes to Condensed Financial Statements
                 Three and six months ended September 30, 2021
                                  (Unaudited)



Note 7 - Notes Payable:



Notes payable was approximately $0.4 million as of September 30, 2021 and March 31, 2021, respectively, and primarily consisted of its Paycheck Protection Loan.





Paycheck Protection Loan



On April 24, 2020 and March 3, 2021, the Company entered into Promissory Notes
(the "PPP Notes") with Newtek Corp AVB as the lender (the "Lender"), pursuant to
which the Lender agreed to make loans to the Company under the Paycheck
Protection Program (the "PPP Loan") offered by the U.S. Small Business
Administration (the "SBA") in principal amounts of $197,200 and $233,300
pursuant to Title 1 of the Coronavirus Aid, Relief and Economic Security Act
(the "CARES Act").



The PPP Loan proceeds are available to be used to pay for payroll costs,
including salaries, commissions, and similar compensation, group health care
benefits, and paid leaves; rent; utilities; and interest on certain other
outstanding debt. The Loan is subject to forgiveness to the extent proceeds are
used for payroll costs, including payments required to continue group health
care benefits, and certain rent, utility, and mortgage interest expenses
(collectively, "Qualifying Expenses"), pursuant to the terms and limitations of
the PPP Loan. The Company used the PPP Loan amounts against Qualifying Expenses
and has initiated the process of loan forgiveness for the first tranche of
$197,200. The Company anticipates that both loan principals will be fully
forgiven. The interest rate on the PPP Notes is a fixed rate of 1% per annum and
the PPP Notes mature in two years.



The PPP Notes include events of default. Upon the occurrence of an event of default, the Lender will have the right to exercise remedies against the Company, including the right to require immediate payment of all amounts due under the PPP Notes.

On June 17, 2020, the Company received an Economic Injury Disaster Loan totaling $8,000 from the U.S. Small Business Administration.

Note 8 - Stockholders' Equity (Deficit)





Preferred Stock


As of September 30, 2021 and March 31, 2021, there were 50,000,000 authorized shares of the Company's preferred stock, par value $0.0001.





Series A Preferred Sock


As of September 30, 2021 and March 31, 2021, the Company had 251 shares of its Series A preferred stock issued and outstanding.





Series B Preferred Stock


As of September 30, 2021 and March 31, 2021, the Company had 1,443 shares of its Series B preferred stock issued and outstanding.





Series C Preferred Stock


As of September 30, 2021 and March 31, 2021, the Company had 500,756 shares of its Series C preferred stock issued and outstanding.





Common Stock



Stock Issued for Services



During the six months ended September 30, 2021, the Company issued 64,261 shares
of its common stock with a fair value of approximately $0.2 million in exchange
for consulting services.



                                       10





                          CROWN ELECTROKINETICS, CORP.
                    Notes to Condensed Financial Statements
                 Three and six months ended September 30, 2021
                                  (Unaudited)



Stock Options


During the six months ended September 30, 2021, the Company issued 409,385 shares of its common stock in connection with the exercise of stock options and received proceeds of approximately $0.2 million.





During the year ended March 31, 2021, the Company issued 25,000 shares of its
common stock in connection with the exercise of stock options, with an exercise
price of $0.15 per share. During April 2021, the Company received the related
proceeds of $3,750.


Note 9 - Stock-Based Compensation, Restricted Stock and Stock Options:

Equity Compensation Plan Information:


On December 16, 2020, the Company adopted its 2020 Long-Term Incentive Plan (
the "2020 Plan"). Under the 2020 Plan, there are 5,333,333 shares of the
Company's common stock available for issuance and the 2020 Plan has a term of 10
years. The available shares in the 2020 Plan will automatically increase on the
first trading day in January of each calendar year during the term of this Plan,
commencing with January 2021, by an amount equal to the lesser of (i) five
percent (5%) of the total number of shares of common stock issued and
outstanding on December 31 of the immediately preceding calendar year, (ii)
1,000,000 shares of common stock or (iii) such number of shares of common stock
as may be established by the Company's Board of Directors.



The Company grants equity-based compensation under its 2020 Plan and its 2016
Equity Incentive Plan (the "2016 Plan"). The 2020 Plan and 2016 Plan allows the
Company to grant incentive and nonqualified stock options, and shares of
restricted stock to its employees, directors and consultants. As of September
30, 2021, there is a total of 7,333,333 shares of the Company's common stock
available under the 2016 Plan.



Under the 2016 Plan and the 2020 Plan, upon the exercise of stock options and
issuance of fully vested restricted common stock, shares of common stock may be
withheld to satisfy tax withholdings. As of September 30, 2021, the Company
intends to net settle certain employee options to ensure adequate authorized
shares under the Incentive Plan.



Stock-based compensation:



The Company recognized total expenses for stock-based compensation during the
three and six months ended September 30, 2021 and 2020, which are included in
the accompanying statements of operations, as follows (in thousands):



                                                       Three months ended                     Six months ended
                                                         September 30,                         September 30,
                                                    2021                2020               2021              2020
                                                (Unaudited)          (Unaudited)       (Unaudited)        (Unaudited)

Research and development expenses              $          113       $         141     $          145     $       1,293
Selling, general and administrative expenses            2,988                 830              5,539             7,757
Total stock-based compensation                 $        3,101       $      

  971     $        5,684     $       9,050




Restricted stock units:


A summary of the Company's restricted stock activity during the six months ended September 30, 2021 is as follows (unaudited):





                                                              Weighted
                                                               Average
                                              Number of      Grant-Date
                                               Shares        Fair Value
Unvested at March 31, 2021                     1,061,905     $      4.50
Granted                                        1,200,000     $      4.74
Vested                                          (222,222 )   $      4.78

Unvested at September 30, 2021 (unaudited) 2,039,683 $ 4.61






                                       11





                          CROWN ELECTROKINETICS, CORP.
                    Notes to Condensed Financial Statements
                 Three and six months ended September 30, 2021
                                  (Unaudited)


Upon the Company's uplisting to Nasdaq in January 2021, the Company granted 1,061,905 restricted stock units with a fair value of approximately $4.7 million to the Company's Chief Executive Officer.


During the six months ended September 30, 2021, the Company granted 800,000
restricted stock units with a fair value of approximately $4.1 million, in
exchange for 800,000 restricted stock awards issued to an officer of the Company
and a consultant during the fiscal year ended March 31, 2021. The fair value and
vesting terms of the restricted stock units are identical to the terms of the
restricted stock awards, and therefore, no incremental stock-based compensation
has been recognized during the six months ended September 30, 2021.



During the six months ended September 30, 2021, the Company granted 400,000 restricted stock units with a fair value of approximately $1.3 million to its Chief Financial Officer.





During the three and six months ended September 30, 2021, the Company recognized
stock-based compensation of approximately $2.0 million and $3.8 million,
respectively, related to restricted stock. During the three months ended
September 30, 2020, the Company recognized stock-based compensation of
approximately $0.2 million and $4.5 million, respectively, related to restricted
stock. As of September 30, 2021, unrecognized stock-based compensation totaled
approximately $4.4 million.



Restricted stock awards:


A summary of the Company's restricted stock activity during the six months ended September 30, 2021 is as follows (unaudited):





                                                                Number of         Weighted Average
                                                                 Shares        Grant-Date  Fair Value
Unvested at March 31, 2021                                         777,778     $                 5.12
Vested                                                             (66,666 )   $                 5.12
Canceled                                                          (711,112 )   $                 5.12

Unvested at September 30, 2021 (unaudited)                               - 

   $                 5.12




During the six months ended September 30, 2021, 66,666 shares of the Company's
restricted stock awards vested. During the six months ended September 30, 2021,
the Company exchanged 88,888 shares of its vested restricted stock awards and
711,112 of its unvested restricted stock awards for restricted stock units.

(See
Restricted stock units).



Stock Options:



The Company provides stock-based compensation to employees, directors and
consultants under the Plan. The fair value of each stock option grant is
estimated on the date of grant using the Black-Scholes option pricing model. The
Company historically has been a private company and lacks company-specific
historical and implied volatility information. Therefore, it estimates its
expected stock volatility based on the historical volatility of a publicly
traded set of peer companies and expects to continue to do so until such time as
it has adequate historical data regarding the volatility of its own traded stock
price. The risk-free interest rate is determined by referencing the U.S.
Treasury yield curve in effect at the time of grant of the award for time
periods approximately equal to the expected term of the award. Expected dividend
yield is based on the fact that the Company has never paid cash dividends and
does not expect to pay any cash dividends in the foreseeable future.



During the six months ended September 30, 2021, the Company granted 1,227,204
options to purchase shares of the Company's common stock to members of the
Company's Board of Directors, employees and consultants. The options have a fair
value of approximately $1.9 million.



The following was used in determining the fair value of stock options granted
during the three and six months ended September 30, 2021 and 2020 (unaudited).



                                   Three Months Ended                     Six Months Ended
                                      September 30,                         September 30,
                                2021               2020               2021               2020
Dividend yield                    0%                 0%                 0%                 0%
Expected price volatility         50%                50%                50%                50%
Risk free interest rate       0.66%-1.30%       0.16% - 0.44%       0.35%-1.30%       0.16% - 0.44%
Expected term                  5-7 years          5-6 years          3-7 years          5-6 years




                                       12





                          CROWN ELECTROKINETICS, CORP.
                    Notes to Condensed Financial Statements
                 Three and six months ended September 30, 2021
                                  (Unaudited)


A summary of activity under the Plan for the six months ended September 30, 2021 is as follows (in thousands except share and per share amounts):





                                                                                     Weighted
                                                                  Weighted       Average Remaining
                                                   Shares         Average           Contractual          Aggregate
                                                 Underlying       Exercise             Term              Intrinsic
                                                  Options          Price              (Years)              Value

Outstanding at March 31, 2019                      1,937,833     $     0.54                     9.2     $ 3,720,395
Outstanding at March 31, 2020                      1,937,833     $     0.54

                    8.2     $ 4,243,610
Granted                                            8,949,107     $     3.23                     8.4
Exercised                                            (25,000 )   $     0.15                       -

Outstanding at March 31, 2021                     10,928,607 *   $     2.73

                    8.2     $    17,524
Granted                                            1,227,204     $     3.49                     9.8
Exercised                                           (419,000 )   $     0.51                       -
Canceled                                            (816,379 )   $     3.88                       -

Outstanding at September 30, 2021 (unaudited)     10,920,432     $     2.83                     7.8     $    13,089

Exercisable at September 30, 2021 (unaudited)      9,756,406     $     2.73

                    7.7     $    12,483

* Options outstanding as of March 31, 2021 includes 66,667 options to purchase

shares of the Company's common stock granted on October 16, 2020 and were

recorded as an out of period adjustment. The related stock-based compensation

of approximately $0.2 million has been expensed during the six months ended

September 30, 2021.




During the three and six months ended September 30, 2021, the Company recognized
stock-based compensation of approximately $0.3 million and $0.9 million,
respectively, related to stock options. During the three and six months ended
September 30, 2020, the Company recognized stock-based compensation of
approximately $0.6 million and $4.4 million, respectively, related to stock
options. As of September 30, 2021, the Company had approximately $1.4 million of
unrecognized compensation expense related to options granted under the Company's
equity incentive plan, which is expected to be recognized over a
weighted-average period of 1.7 years.



Warrants:



A summary of the Company's warrant activity during the six months ended
September 30, 2021 is as follows (in thousands except share and per share
amounts):



                                                                                    Weighted
                                                                 Weighted       Average Remaining
                                                  Shares         Average           Contractual          Aggregate
                                                Underlying       Exercise             Term              Intrinsic
                                                 Warrants         Price              (Years)              Value

Outstanding at March 31, 2021                     3,883,083     $     2.49
                   4.6     $     7,763
Issued                                              550,724     $     4.07                     5.0
Canceled                                           (133,630 )   $     5.63                       -

Outstanding at September 30, 2021 (unaudited)     4,300,177     $     2.60                     4.2     $     7,026

Exercisable at September 30, 2021 (unaudited)     3,368,422     $     1.91
                   4.1     $     6,447
During the six months ended September 30, 2021, the Company issued 550,724
common stock warrants in exchange for consulting and advisory services. The
warrants have a fair value of approximately $0.7 million which is recorded as
stock-based compensation in the accompanying condensed statement of operations
for the three and six months ended September 30, 2021.



                                       13





                          CROWN ELECTROKINETICS, CORP.
                    Notes to Condensed Financial Statements
                 Three and six months ended September 30, 2021
                                  (Unaudited)


The following was used in determining the fair value of warrants issued during the three and six months ended September 30, 2021 and 2020 (unaudited).





                                                                Three Months Ended        Six Months Ended
                                                                   September 30,            September 30,
                                                                       2021                     2021
Dividend yield                                                            0%                       0%
Expected price volatility                                                 50%                      50%
Risk free interest rate                                               0.66%-1.30%              0.35%-1.30%
Expected term                                                          5-7 years                3-7 years



Note 10 - Commitments and Contingencies





Leases



Oregon State University



On March 8, 2016, the Company entered into a lease agreement with Oregon State
University, to lease office and laboratory space located at HP Campus Building
11, 1110 NE Circle Blvd, Corvallis, Oregon, for approximately $400 monthly. On
July 1, 2016, the Company entered into the first amendment to the lease
agreement which increased the monthly lease expense to approximately $1,200. On
October 1, 2017, the Company entered into a sublease agreement, which provides
for additional office space and the monthly lease payment increased to
approximately $1,800. The lease expired on June 30, 2018 and the Company
extended the lease through June 30, 2019. The monthly lease payment increased to
approximately $4,500 for the months ended June 30 2018 through November 30, 2018
and increased to approximately $7,550 for the months ended December 31, 2018
through June 30, 2019.



On July 1, 2019, the Company entered into the fourth amendment to its lease with
Oregon State University, which extends the lease expiration date to June 30,
2022. Beginning on July 1, 2020, and each July 1 thereafter, the monthly
Operating Expense Reimbursement, as defined will be increased by no more than
three percent.



On July 1, 2020, the Company entered into the fifth amendment to its lease with
Oregon State University which adjusts the Operating Expense Reimbursement
payment due dates from monthly to quarterly, with the payments due in advance on
the first of July, October, January and April. Effective July 1, 2020, the
quarterly operating expense will be $23,097.



On September 1, 2021, the Company entered into the seventh amendment to its
lease with Oregon State University which expands the lease to now include
approximately 703 square feet of lab space, 576 square feet of cubicle space,
1096 square feet of Highbay lab space, and 376 square feet of High bay storage
space in a building commonly known as Building 11. Effective September 1, 2021,
the quarterly operating expense will be $31,647 covering all utility and
facility tooling costs. The sublease is extended until June 30, 2025.



                                       14





                          CROWN ELECTROKINETICS, CORP.
                    Notes to Condensed Financial Statements
                 Three and six months ended September 30, 2021
                                  (Unaudited)



Hudson 11601 Wilshire, LLC



On March 4, 2021, the Company entered into a lease agreement with Hudson 11601
Wilshire, LLC, to lease 3,500 square feet of office space located in Los
Angeles, California. The lease term is 39 months and expires on June 30, 2024.
The monthly lease expense is as follows:



  ? Months 1-12 - $18,375




  ? Months 13-24 - $19,018




  ? Months 25-36 - $19,684




  ? Months 37-39 - $20,373

The Company paid a security deposit totaling $20,373 at the lease inception date.





HP Inc.



On May 4, 2021, the Company entered into a lease agreement with HP Inc. to lease
office and lab space located in HP Campus Building 11, 1110 NE Circle Blvd,
Corvallis, Oregon. The lease term is 5 years and the lease commencement date was
April 1, 2021. The monthly lease expense is $7,388 and increases 3% on each
anniversary of the lease commencement date. The Company paid a security deposit
totaling $8,315. The Company has the option to extend the lease for an
additional 5 years.



Pacific N.W. Properties, LLC
On October 5, 2021, the Company entered into a lease agreement with Pacific N.W.
Properties, LLC to lease 26,963 square feet of warehouse, manufacturing,
production and office space located in Salem Oregon. The commencement date of
the lease is October 1, 2021, the lease term is 62 months and expires on
November 30, 2026. The monthly lease expense is as follows:



  ? Months 1-2   - $0

  ? Months 3-12  - $21,500

  ? Months 13-24 - $22,145

  ? Months 25-36 - $22,809

  ? Months 37-48 - $23,494

  ? Months 49-60 - $24,198

  ? Months 61-62 - $24,924

The amounts owed by the Company on the lease inception date is $176,500, including, a performance deposit totaling $150,000, the third month's rent of $21,500 and other payments of $5,000.





During the three months ended September 30, 2021 and 2020, the Company
recognized rent expense of approximately $0.1 million and $23,000, respectively.
During the six months ended September 30, 2021 and 2020, the Company recognized
rent expense of approximately $0.2 million and $47,000, respectively.



                                       15





                          CROWN ELECTROKINETICS, CORP.
                    Notes to Condensed Financial Statements
                 Three and six months ended September 30, 2021
                                  (Unaudited)


As of September 30, 2021, future minimum payments are as follows (in thousands):





Six months ended March 31, 2022            $   346
Year ended March 31, 2023                      601
Year ended March 31, 2024                      580
Year ended March 31, 2025                      411
Year ended March 31, 2026 and thereafter       543
Total                                      $ 2,481




Litigation



In August 2019, Spencer Clarke LLC ("Spencer Clarke") filed a lawsuit against
the Company in the Supreme Court of the State of New York, County of New York,
Index No. 654592/2019. Spencer Clarke has asserted claims arising from a 2018
Placement Agent Agreement (the "Placement Agent Agreement") under which Spencer
Clarke agreed to assist the Company in raising money for a potential public
offering. Spencer Clarke claims that the Company failed to make certain payments
under that Placement Agent Agreement. On September 27, 2019, the Company filed a
motion to dismiss the complaint. On October 7, 2019, Spencer Clarke amended the
complaint. On November 8, 2019, the Company filed an Answer and asserted
Counterclaims against Spencer Clarke alleging breach of contract, anticipatory
repudiation, and tortious interference with prospective business relations. On
or about September 22, 2021, the Company and Spencer Clarke executed a
Settlement and Release Agreement, the terms of which are confidential. As a
result, on September 24, 2021, the parties filed a Stipulation of Discontinuance
With Prejudice with the Court, and on September 30, 2021, the Court formally
discontinued the action.


From time to time, the Company is also involved in various other claims and legal actions that arise in the ordinary course of business. Although the results of litigation and claims cannot be predicted with certainty, the Company does not believe that the ultimate resolution of these actions will have a material adverse effect on its financial position, results of operations, liquidity or capital resources.


Future litigation may be necessary to defend ourselves and our partners by
determining the scope, enforceability and validity of third party proprietary
rights or to establish the Company's proprietary rights. The results of any
current or future litigation cannot be predicted with certainty, and regardless
of the outcome, litigation can have an adverse impact on the Company because of
defense and settlement costs, diversion of management resources and other
factors.



Note 11 - Subsequent Events


The Company has evaluated all events that occurred after the balance sheet date of September 30, 2021, through November 12, 2021, the date when condensed financial statements were issued to determine if they must be reported.





                                       16




Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS





The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with the condensed financial statements
and related notes thereto included elsewhere in this report. This discussion
contains forward-looking statements that involve risks and uncertainties. Our
actual results could differ materially from those discussed below. Factors that
could cause or contribute to such differences include, but are not limited to,
those identified below and those discussed in the section titled "Risk Factors"
included elsewhere in this report.



Management's plans and basis of presentation:

The Company was incorporated in the State of Delaware on April 20, 2015. Effective January 14, 2016, the Company's name was changed to 3D Nanocolor Corp. ("3D Nanocolor") from 2D Nanocolor Corp. Subsequently, effective October 6, 2017, the Company's name was changed to Crown Electrokinetics Corp. from 3D Nanocolor Corp.

The Company is commercializing technology for smart or dynamic glass. The Company's electrokinetic glass technology is an advancement on microfluidic technology that was originally developed by Hewlett-Packard Company.

On January 26, 2021, the Company completed its public offering and its common stock began trading on the Nasdaq Capital Market (Nasdaq) under the symbol CRKN.





Crown's Research & Development operation is located on the HP Inc. campus in
Corvallis, Oregon in the Advanced Technology and Manufacturing Institute
(ATAMI). ATAMI is an academic-industrial research center and business incubator
designed to provide an advanced materials development environment to private
sector partner tenants performing research and development. The facility
includes access to shared state-of-the-art tooling capabilities.



On September 1, 2021, the Company entered into the seventh amendment to its
lease with Oregon State University, expanding the lease to now include
approximately 703 square feet of lab space, 576 square feet of cubicle space,
1096 square feet of Highbay lab space, and 376 square feet of High bay storage
space in a building commonly known as Building 11. Effective September 1, 2021,
the quarterly operating expense will be $31,647.03 which contemplates overhead
utilities and facility tooling costs. The sublease is extended until June 30,
2025.



On October 5, 2021 the Company entered into a lease for 27,000 square feet of
manufacturing space located at 3350 Pipebend Place NE, Salem, Oregon, 97301.
This building will be used for the manufacture and assembly of the Company's
first product, Crown's Smart Window Insert powered by DynamicTintTM. The base
monthly rent for the first year of the lease is $21,500 per month, which
increases to $22,145 per month for the second year, $22,809 for the third year,
$23,494 for the fourth year, $24,198 for the fifth year, and $24,924 for the
final month of the lease. The Company paid a security deposit totaling $150,000.
The lease expires on November 30, 2026.



On March 4, 2021, the Company entered into a standard office lease with Hudson
11601 Wilshire, LLC, to lease 3,500 square feet of office space located at 11601
Wilshire Boulevard, Los Angeles, California 90025. The base monthly rent for the
first year of the lease is $18,375 per month, which increases to $19,018 per
month for the second year, $19,684 for the third year and $20,373 for the final
three months of the lease. The lease expires on June 30, 2024.



We believe that our administration, R&D, and manufacturing facilities are adequate to meet our needs for the immediate future and that, should it be needed, we will be able to secure additional space to accommodate the expansion of our operations.


During the six months ended September 30, 2021, the Company entered into a
Patent Assignment Agreement with International Business Machines Corporation
("IBM") to acquire an ownership interest in assigned patents. As consideration
for the patents, the Company paid $231,000 (including legal fees of
approximately $6,000) during the six months ended September 30, 2021.



                                       17





Crown's first product will be the Smart Window Insert for commercial buildings.
Crown's Commercial Building Smart Window Inserts will allow the building owner
to quickly convert its single pane window units to a dual pane window unit.
Crown's inserts will act as the "second pane" and will allow the building owner
to enjoy all the benefits of a dual pane window without having to replace their
existing single pane windows. Crown's Inserts can be integrated into the
building HVAC control system, thereby optimizing the use of our Smart Window
Inserts and reducing the use of the HVAC to heat or cool the rooms utilizing our
technology. Initial field tests of Crown's DynamicTintTMtechnology suggests HVAC
energy savings of 26% could result from the installation of Smart Window Inserts
powered by DynamicTintTM. As Crown's DynamicTint technology requires very little
energy to effect that transition from clear to dark state, a rechargeable
battery coupled with a built-in solar cell eliminates the need to hardwire the
inserts to the building electrical system. Each unit will have wireless
communication capability for control of the film and communication with the
building HVAC system. Crown believes that the potential retrofit market for its
Smart Window Inserts is significant.



Crown is developing its manufacturing capabilities to meet anticipated demand
for the Smart Window Insert through a combination of in-house tooling at its
Corvallis, Oregon premises as well as via contract manufacturing partnerships
which are currently being negotiated.



The Company intends to develop and sell our patented EK Technology under the
name DynamicTintTM. We intend to generate revenue by selling, and in some cases
leasing, DynamicTintTMfilm or Smart Window Inserts powered by DynamicTintTM to
our customers. On September 27, 2021, Crown entered into a Master Supply
Agreement with MetroSpaces Inc. to be the Company's first commercial customer.
The Company will install its Smart Window Inserts in MetroSpaces' 70,000
square-foot Houston, Texas office building. The agreement provides the master
terms and conditions under which Crown will supply units in order to retrofit
certain windows at locations indicated in the purchase orders. In the future,
the parties may enter into multiple specific transactions by executing purchase
orders for additional buildings.



Additionally, discussions with multiple other building owners to buy Crown Smart
Window Inserts are progressing as the regulatory and consumer pressure to reduce
the level of energy consumption and carbon emissions, continues to build.



Results of Operations for the three months ended September 30, 2021 and 2020 (in
thousands):



                                        Three Months Ended
                                           September 30,
                                         2021          2020
Research and development              $      787      $   423
Selling, general and administrative        4,865        1,659
Other expense                                 51        3,685
Net loss                              $    5,703      $ 5,767




Research and Development



Research and development expenses were $0.8 million for the three months ended
September 30, 2021 compared to $0.4 million for the three months ended September
30, 2020. The increase of $0.4 million is primarily related to increased payroll
and related expenses.


Selling, General and Administrative


Selling, general and administrative ("SG&A") expenses were $4.9 million and $1.7
million for the three months ended September 30, 2021 and 2020, respectively.
The $3.2 million increase in SG&A expenses is primarily attributable to
increased stock-based compensation expense of $2.1 million primarily related to
the issuance of restricted stock units and common stock warrants, increases in
payroll and related benefits of $0.4 million due to increased headcount,
increases in legal, professional and consulting fees of $0.4 million, and
increases in operating overhead of $0.3 million.



Other Expense


Other expense was nominal during the three months ended September 30, 2021. Other expense was $3.7 million for the three months ended September 30, 2020, and was primarily due to interest incurred on our convertible notes.





                                       18





Results of Operations for the six months ended September 30, 2021 and 2020 (in
thousands):



                                        Six Months Ended
                                          September 30,
                                        2021         2020
Research and development              $  1,221     $  1,796
Selling, general and administrative      9,827        9,597
Other expense                               53        4,836
Net loss                              $ 11,101     $ 16,229




Research and Development



Research and development expenses were $1.2 million for the six months ended
September 30, 2021 compared to $1.8 million for the six months ended September
30, 2020. The decrease of $0.6 million is primarily related to lower stock-based
compensation expenses of $0.9 million related to options and $0.2 million
related to restricted stock units, offset by increased payroll and related

costs
totaling $0.5 million.


Selling, General and Administrative


Selling, general and administrative ("SG&A") expenses were $9.8 million and $9.6
million for the six months ended September 30, 2021 and 2020, respectively. The
$0.2 million increase in SG&A expenses is primarily attributable to lower
stock-based compensation expense of $2.8 million related to stock options and
$4.1 million for restricted stock awards, offset by increased stock compensation
expense of $3.8 million for restricted stock units and $0.8 million for the
issuance of common stock warrants, increases in payroll and related expenses of
$0.7 million due to increased headcount, bonuses paid to our Chief Executive
Officer of $0.4 million, increased professional fees of $1.1 million, and
increases in operating overhead of $0.3 million.



Other Expense



Other expense was nominal during the six months ended September 30, 2021. Other
expense was $4.8 million for the six months ended September 30, 2020, and was
primarily due to interest incurred on our convertible notes.



Liquidity



The Company has incurred substantial operating losses since its inception, and
expects to continue to incur significant operating losses for the foreseeable
future and may never become profitable. As reflected in the condensed financial
statements, the Company had an accumulated deficit of approximately $68.3
million at September 30, 2021, a net loss of approximately $11.1 million, and
approximately $5.2 million of net cash used in operating activities for the six
months ended September 30, 2021. The Company expects to continue to incur
ongoing administrative and other expenses, including public company expenses.



In November 2021, the Company entered into a non-binding term sheet with a
financial institution in connection with a $10 million Standby Letter of Credit
("SLOC"). The SLOC accrues interest at a rate of 8% per annum and matures two
years from the issuance date of the SLOC. Interest is payable quarterly.



Although it is difficult to predict the Company's liquidity requirements as of
September 30, 2021, based upon the Company's current operating plan, cash on
hand, and SLOC funding, management believes that the Company will have
sufficient cash to meet its projected operating requirements for at least the
next 12 months following the issuance of these condensed financial statements.



                                       19





Cash Flows (in thousands)



                                                             Six Months Ended
                                                               September 30,
                                                             2021         2020

Cash and cash equivalents at the beginning of the period $ 15,297 $

48


Net cash used in operating activities                        (5,236 )     (2,794 )
Net cash used in investing activities                          (546 )        (29 )
Net cash provided by financing activities                       186       

3,376

Cash and cash equivalents at the end of the period $ 9,701 $


 601




Operating Activities


For the six months ended September 30, 2021, net cash used in operating activities was $5.2 million, which primarily consisted of our net loss of $11.1 million, adjusted for non-cash expenses of $5.8 million which primarily consisted of stock-based compensation expenses. The net change in operating assets and liabilities was nominal.





For the six months ended September 30, 2020, net cash used in operating
activities was $2.8 million, which primarily consisted of our net loss of $16.2
million, adjusted for non-cash expenses of $13.9 million including, $9.3 million
of stock-based compensation expenses, $2.0 million of amortization related to
the debt discount recognized for our convertible notes payable, $1.5 million
recognized for the loss on exchange of our convertible notes for common stock
and warrants, $0.7 million for the change in fair value of our warrant
liability, $0.2 million for the loss on extinguishment of debt, and $0.1 million
of other non-cash expenses. The net change in operating assets and liabilities
was $0.4 million and was primarily due to decreases in accounts payable and
accrued expenses totaling $0.6 million, offset by a $0.3 million increase in
accrued interest related to our convertible notes and a 0.1 million increase to
prepaid expenses and other current assets.



Investing Activities



For the six months ended September 30, 2021, net cash used in investing
activities was approximately $0.5 million, consisting of $0.3 million related to
the purchase of property and equipment and $0.2 million for the purchase of

the
IBM patents.


For the six months ended September 30, 2020, net cash used in investing activities was approximately $29,000, related to the purchase of computer equipment and computer software.





Financing Activities


For the six months ended September 30, 2021, net cash provided by financing activities was $0.2 million, related to the exercise of stock options.


For the six months ended September 30, 2020, net cash provided by financing
activities was $3.4 million. The net cash provided is primarily related to $2.1
million of proceeds received from the issuance of our senior secured convertible
notes and the related stock warrants, $1.6 million related to the net proceeds
received from the issuance of the Company's common stock and warrants, and $0.2
million of proceeds received from our PPP loan, offset by $0.2 million for the
repurchase of shares of our common stock and $0.2 million for the repayment of
our senior secured promissory note.



Critical accounting policies and significant judgments and estimates


Our financial statements are prepared in accordance with generally accepted
accounting principles in the United States, or GAAP. The preparation of our
financial statements requires us to make estimates, assumptions and judgments
that affect the reported amounts of assets, liabilities, costs and expenses. We
base our estimates and assumptions on historical experience and other factors
that we believe to be reasonable under the circumstances. We evaluate our
estimates and assumptions on an ongoing basis. Our actual results may differ
from these estimates. Our most critical accounting policies are summarized
below. See Note 3 to our condensed financial statements for a description of our
other significant accounting policies.



Recent accounting pronouncements

See Note 3 to our condensed financial statements for a description of recent accounting pronouncements applicable to our financial statements.





JOBS Act Transition Period



As an "emerging growth company" under the Jumpstart Our Business Startups Act of
2012, we can take advantage of an extended transition period for complying with
new or revised accounting standards. This allows an emerging growth company to
delay the adoption of certain accounting standards until those standards would
otherwise apply to private companies. We are electing to delay our adoption of
such new or revised accounting standards. As a result of this election, our
financial statements may not be comparable to the financial statements of other
public companies.



                                       20

© Edgar Online, source Glimpses